These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32286246)

  • 1. COVID-19 infections are also affected by human ACE1 D/I polymorphism.
    Delanghe JR; Speeckaert MM; De Buyzere ML
    Clin Chem Lab Med; 2020 Jun; 58(7):1125-1126. PubMed ID: 32286246
    [No Abstract]   [Full Text] [Related]  

  • 2. Could angiotensin-converting enzyme 1
    Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
    J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
    [No Abstract]   [Full Text] [Related]  

  • 3. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.
    Su S; Jiang S
    Signal Transduct Target Ther; 2020 May; 5(1):71. PubMed ID: 32435059
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
    Alshahawey M; Raslan M; Sabri N
    Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.
    Gómez J; Albaiceta GM; García-Clemente M; López-Larrea C; Amado-Rodríguez L; Lopez-Alonso I; Hermida T; Enriquez AI; Herrero P; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Cuesta-Llavona E; Alvarez V; Lorca R; Coto E
    Gene; 2020 Dec; 762():145102. PubMed ID: 32882331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
    Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
    Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
    [No Abstract]   [Full Text] [Related]  

  • 7. Host Polymorphisms May Impact SARS-CoV-2 Infectivity.
    Brest P; Refae S; Mograbi B; Hofman P; Milano G
    Trends Genet; 2020 Nov; 36(11):813-815. PubMed ID: 32828550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections.
    Delanghe JR; Speeckaert MM; De Buyzere ML
    Clin Chim Acta; 2020 Jun; 505():192-193. PubMed ID: 32220422
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 Infections: An ACE in the Hole and Systems Biology Studies-a Research Agenda.
    Poland GA; Bass J; Goldstein MR
    Mayo Clin Proc; 2020 Sep; 95(9):1838-1841. PubMed ID: 32861326
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
    Yamamoto N; Ariumi Y; Nishida N; Yamamoto R; Bauer G; Gojobori T; Shimotohno K; Mizokami M
    Gene; 2020 Oct; 758():144944. PubMed ID: 32628976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic and epigenetic variability, and the Covid-19 pandemic].
    Rivera-Silva G
    Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Are there genetic variants that can modify the course of the COVID-19 pandemic?].
    Azurmendi PJ
    Medicina (B Aires); 2020; 80 Suppl 3():79-81. PubMed ID: 32658852
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic predisposition models to COVID-19 infection.
    Darbeheshti F; Rezaei N
    Med Hypotheses; 2020 Sep; 142():109818. PubMed ID: 32416414
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE2 Expression and Risk Factors for COVID-19 Severity in Patients with Advanced Age.
    Tavares CAM; Avelino-Silva TJ; Benard G; Cardozo FAM; Fernandes JR; Girardi ACC; Jacob Filho W
    Arq Bras Cardiol; 2020 Oct; 115(4):701-707. PubMed ID: 33111872
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex-derived attributes contributing to SARS-CoV-2 mortality.
    Chanana N; Palmo T; Sharma K; Kumar R; Graham BB; Pasha Q
    Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E562-E567. PubMed ID: 32726128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can estrogens protect against COVID-19? The COVID-19 puzzling and gender medicine.
    Bonaccorsi G; Gambacciani M; Gemmati D
    Minerva Ginecol; 2020 Jun; 72(3):178-179. PubMed ID: 33000616
    [No Abstract]   [Full Text] [Related]  

  • 17. Covid-19 infection and the host genetic predisposition: does it exist?
    Vašků A
    Physiol Res; 2020 Jul; 69(3):511-514. PubMed ID: 32682363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.
    Darbani B
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32423095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium status and kidney involvement during COVID-19 infection.
    Post A; Dullaart RPF; Bakker SJL
    Virus Res; 2020 Sep; 286():198034. PubMed ID: 32445872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression.
    Hatami N; Ahi S; Sadeghinikoo A; Foroughian M; Javdani F; Kalani N; Fereydoni M; Keshavarz P; Hosseini A
    Endocrine; 2020 Jun; 68(3):479-484. PubMed ID: 32542429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.